216 related articles for article (PubMed ID: 24442715)
21. [How to recognize scleroderma].
Francès C; Ayoub N; Barete S
Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
[TBL] [Abstract][Full Text] [Related]
22. [Mimetics of systemic sclerosis].
Jendrek ST; Kahle B; Riemekasten G
Z Rheumatol; 2019 Feb; 78(1):14-23. PubMed ID: 30255410
[TBL] [Abstract][Full Text] [Related]
23. Morphea and localized scleroderma in children.
Vierra E; Cunningham BB
Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
[TBL] [Abstract][Full Text] [Related]
24. Na+ deposition in the fibrotic skin of systemic sclerosis patients detected by 23Na-magnetic resonance imaging.
Kopp C; Beyer C; Linz P; Dahlmann A; Hammon M; Jantsch J; Neubert P; Rosenhauer D; Müller DN; Cavallaro A; Eckardt KU; Schett G; Luft FC; Uder M; Distler JHW; Titze J
Rheumatology (Oxford); 2017 Apr; 56(4):556-560. PubMed ID: 28013199
[TBL] [Abstract][Full Text] [Related]
25. Skin substitute-assisted repair shows reduced dermal fibrosis in acute human wounds validated simultaneously by histology and optical coherence tomography.
Greaves NS; Iqbal SA; Hodgkinson T; Morris J; Benatar B; Alonso-Rasgado T; Baguneid M; Bayat A
Wound Repair Regen; 2015; 23(4):483-94. PubMed ID: 26053202
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers for skin involvement and fibrotic activity in scleroderma.
Moinzadeh P; Denton CP; Abraham D; Ong V; Hunzelmann N; Eckes B; Krieg T
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):267-76. PubMed ID: 21819452
[TBL] [Abstract][Full Text] [Related]
27. Systemic and localized scleroderma.
Chung L; Lin J; Furst DE; Fiorentino D
Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
[TBL] [Abstract][Full Text] [Related]
28. [Nephrogenic systemic fibrosis].
Artunc F; Schanz S; Metze D; Heyne N
Dtsch Med Wochenschr; 2008; 133 Suppl():F1. PubMed ID: 18802876
[TBL] [Abstract][Full Text] [Related]
29. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions.
Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A
Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497
[TBL] [Abstract][Full Text] [Related]
30. Quantitative Assessment of Skin Stiffness Using Ultrasound Shear Wave Elastography in Systemic Sclerosis.
Yang Y; Qiu L; Wang L; Xiang X; Tang Y; Li H; Yan F
Ultrasound Med Biol; 2019 Apr; 45(4):902-912. PubMed ID: 30665723
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
Zhu H; Luo H; Zuo X
Exp Mol Med; 2013 Sep; 45(9):e41. PubMed ID: 24052166
[TBL] [Abstract][Full Text] [Related]
32. Assessing the progression of systemic sclerosis by monitoring the tissue optic axis using PS-OCT.
Adams DC; Szabari MV; Lagares D; McCrossan AF; Hariri LP; Tager AM; Suter MJ
Sci Rep; 2020 Feb; 10(1):2561. PubMed ID: 32054932
[TBL] [Abstract][Full Text] [Related]
33. Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis.
Vañó Sanchis D; Arranz Garcia G; Yglesias PJ
Clin Rheumatol; 2006 May; 25(3):382-3. PubMed ID: 16211337
[No Abstract] [Full Text] [Related]
34. Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration.
Kanal E; Patton TJ; Krefting I; Wang C
AJNR Am J Neuroradiol; 2020 Mar; 41(3):393-399. PubMed ID: 32115422
[TBL] [Abstract][Full Text] [Related]
35. Pigmented skin patches without scleroderma as a predominant clinical symptom revealing systemic sclerosis.
Darrigade AS; Vedie AL; Gauthier C; Cario-André M; Taieb A; Truchetet ME; Constans J; Seneschal J
Clin Exp Dermatol; 2016 Jun; 41(4):379-82. PubMed ID: 27171356
[TBL] [Abstract][Full Text] [Related]
36. A novel approach to measuring skin elasticity in systemic sclerosis: results from a pilot study.
Galarraga B; McSwiggan S; Caswell FR; Brodie RC; Sharma P; Abel EW; Newton DJ; Belch JJ
Scand J Rheumatol; 2011 May; 40(3):211-6. PubMed ID: 21231806
[TBL] [Abstract][Full Text] [Related]
37. Skin imaging in systemic sclerosis.
Kang T; Abignano G; Lettieri G; Wakefield RJ; Emery P; Del Galdo F
Eur J Rheumatol; 2014 Sep; 1(3):111-116. PubMed ID: 27708890
[TBL] [Abstract][Full Text] [Related]
38. [Non-invasive assessment of liver fibrosis].
Cohen-Ezra O; Ben-Ari Z
Harefuah; 2015 Mar; 154(3):204-7, 210, 209. PubMed ID: 25962254
[TBL] [Abstract][Full Text] [Related]
39. Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
Sunderkötter C; Kuhn A; Hunzelmann N; Beissert S
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii52-iii54. PubMed ID: 16987838
[TBL] [Abstract][Full Text] [Related]
40. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
